Keyphrases
C-reactive Protein to Albumin Ratio
40%
Cancer Patients
100%
Chemotherapy
20%
Cut-off Level
20%
First-line Regimen
20%
Gemcitabine
100%
Hazard Ratio
20%
Inflammatory Markers
100%
Multivariate Analysis
20%
Neutrophil-to-lymphocyte Ratio
40%
Overall Survival
20%
Palliative Chemotherapy
100%
Pancreatic Cancer
100%
Platelet-to-lymphocyte Ratio
40%
Poor Clinical Outcomes
20%
Prognostic Indicator
100%
Receiver Operating Characteristic Analysis
20%
Resectable Pancreatic Cancer
40%
Single-center Retrospective Study
20%
Survival Prediction
20%
Survival Rate
60%
Therapeutic Strategies
20%
Univariate Analysis
20%
Medicine and Dentistry
C Reactive Protein
33%
Chemotherapy
100%
Gemcitabine
100%
Hazard Ratio
16%
Lymphocyte
66%
Malignant Neoplasm
16%
Multivariate Analysis
16%
Neutrophil
33%
Overall Survival
16%
Pancreas Cancer
100%
Platelet
33%
Retrospective Study
16%
Survival Rate
50%
Univariate Analysis
16%
Pharmacology, Toxicology and Pharmaceutical Science
C Reactive Protein
33%
Chemotherapy
100%
Gemcitabine
100%
Malignant Neoplasm
16%
Overall Survival
16%
Pancreas Cancer
100%
Retrospective Study
16%
Survival Rate
50%